Dexmedetomidine attenuates hypoxia/reoxygenation-induced cardiomyocyte injury in association with ADRA2A/ADRA2B and Notch1/Hes1 modulation

Dinghao Xue, Xinlu Chang, Mingru Zhang, Guyan Wang

Open source

DOI
10.1007/s00210-026-05929-y
Published
2026-09-25
Container
Naunyn-Schmiedeberg's Archives of Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-05929-y,
  title = {Dexmedetomidine attenuates hypoxia/reoxygenation-induced cardiomyocyte injury in association with ADRA2A/ADRA2B and Notch1/Hes1 modulation},
  author = {Dinghao Xue and Xinlu Chang and Mingru Zhang and Guyan Wang},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  doi = {10.1007/s00210-026-05929-y},
  url = {https://doi.org/10.1007/s00210-026-05929-y}
}

RIS

TY  - JOUR
TI  - Dexmedetomidine attenuates hypoxia/reoxygenation-induced cardiomyocyte injury in association with ADRA2A/ADRA2B and Notch1/Hes1 modulation
AU  - Dinghao Xue
AU  - Xinlu Chang
AU  - Mingru Zhang
AU  - Guyan Wang
PY  - 2026
JO  - Naunyn-Schmiedeberg's Archives of Pharmacology
DO  - 10.1007/s00210-026-05929-y
UR  - https://doi.org/10.1007/s00210-026-05929-y
ER  - 

APA

Xue, D., Chang, X., Zhang, M., & Wang, G. (2026). Dexmedetomidine attenuates hypoxia/reoxygenation-induced cardiomyocyte injury in association with ADRA2A/ADRA2B and Notch1/Hes1 modulation. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05929-y

Source records